Emerald Advisers’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.7M	Sell	37,654 -1,259	-3%	-$601K	0.62%	69
2025 Q4	$22.7M	Sell	38,913 -11,824	-23%	-$6.04M	0.7%	65
2025 Q3	$23.3M	Sell	50,737 -2,371	-4%	-$885K	0.75%	57
2025 Q2	$16.1M	Buy	53,108 +5,199	+11%	+$1.55M	0.59%	68
2025 Q1	$15.9M	Buy	47,909 +20,643	+76%	+$6.78M	0.71%	57
2024 Q4	$8.41M	Buy	27,266 +1	+0%	+$281	0.33%	91
2024 Q3	$5.79M	Sell	27,265 -69,499	-72%	-$17.8M	0.22%	109
2024 Q2	$27.1M	Sell	96,764 -4,859	-5%	-$1.16M	1.14%	28
2024 Q1	$27.1M	Buy	101,623 +53,901	+113%	+$12.7M	1.09%	29
2023 Q4	$11M	Buy	47,722 +46,844	+5,335%	+$8.2M	0.47%	85
2023 Q3	$128K	Sell	878 -60,605	-99%	-$11.4M	0.01%	212
2023 Q2	$14.2M	Sell	61,483 -20,581	-25%	-$5.57M	0.62%	75
2023 Q1	$19.9M	Buy	82,064 +69,076	+532%	+$18.8M	0.95%	37
2022 Q4	$3.77M	Buy	+12,988	New	+$1.27M	0.18%	110